BindingDB PrimarySearch

Report error Found 7 Enz. Inhib. hit(s) with Target = 'Histone H1.0'

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)

Ki: 1nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)

Ki: 2nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)

Ki: 10nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)

Ki: 14nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)

Ki: 15nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)

Ki: 28nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair

Histone H1.0(Human)
Intra-Cellular Therapies

US Patent

BDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)

Ki: 780nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair